<qa>  What is the name of the lower-dose MOAB ACA125 subcutaneously?- Arm III: Patients receive lower-dose MOAB ACA125 subcutaneously SC on weeks 0, 2, 4, 6, 10, and 14 in the absence of disease progression or unacceptable toxicity. 